224 related articles for article (PubMed ID: 25672588)
1. APE1/Ref-1 as a Serological Biomarker for the Detection of Bladder Cancer.
Shin JH; Choi S; Lee YR; Park MS; Na YG; Irani K; Lee SD; Park JB; Kim JM; Lim JS; Jeon BH
Cancer Res Treat; 2015 Oct; 47(4):823-33. PubMed ID: 25672588
[TBL] [Abstract][Full Text] [Related]
2. Urinary APE1/Ref-1: A Potential Bladder Cancer Biomarker.
Choi S; Shin JH; Lee YR; Joo HK; Song KH; Na YG; Chang SJ; Lim JS; Jeon BH
Dis Markers; 2016; 2016():7276502. PubMed ID: 27057081
[TBL] [Abstract][Full Text] [Related]
3. Apurinic/Apyrimidinic Endonuclease 1/Redox Factor-1 Could Serve as a Potential Serological Biomarker for the Diagnosis and Prognosis of Oral Squamous Cell Carcinoma.
Xie J; Li Y; Kong J; Li C
J Oral Maxillofac Surg; 2019 Apr; 77(4):859-866. PubMed ID: 30611690
[TBL] [Abstract][Full Text] [Related]
4. Antitumor Activity and Mechanistic Characterization of APE1/Ref-1 Inhibitors in Bladder Cancer.
Fishel ML; Xia H; McGeown J; McIlwain DW; Elbanna M; Craft AA; Kaimakliotis HZ; Sandusky GE; Zhang C; Pili R; Kelley MR; Jerde TJ
Mol Cancer Ther; 2019 Nov; 18(11):1947-1960. PubMed ID: 31413178
[TBL] [Abstract][Full Text] [Related]
5. Impact of apurinic/apyrimidinic endonuclease 1/redox factor-1 on treatment response and survival in oral squamous cell carcinoma.
Hsia KT; Liu CJ; Mar K; Lin LH; Lin CS; Cheng MF; Lee HS; Chiu SY
Head Neck; 2016 Apr; 38(4):550-9. PubMed ID: 25482590
[TBL] [Abstract][Full Text] [Related]
6. Alterations in the expression of the apurinic/apyrimidinic endonuclease-1/redox factor-1 (APE1/Ref-1) in human ovarian cancer and indentification of the therapeutic potential of APE1/Ref-1 inhibitor.
Zhang Y; Wang J; Xiang D; Wang D; Xin X
Int J Oncol; 2009 Nov; 35(5):1069-79. PubMed ID: 19787261
[TBL] [Abstract][Full Text] [Related]
7. Downregulation of apurinic/apyrimidinic endonuclease 1/redox factor-1 enhances the sensitivity of human pancreatic cancer cells to radiotherapy in vitro.
Chen S; Xiong G; Wu S; Mo J
Cancer Biother Radiopharm; 2013 Mar; 28(2):169-76. PubMed ID: 23268706
[TBL] [Abstract][Full Text] [Related]
8. Clinical value of serum Ape1/Ref-1 combined with TGF-β1 monitoring in predicting the occurrence of radiation pneumonitis (RP) in non-small cell lung cancer patients.
Zhang Y; You H; Duan J; Gao Y
Ann Palliat Med; 2021 Mar; 10(3):3328-3335. PubMed ID: 33849117
[TBL] [Abstract][Full Text] [Related]
9. Elevation of Serum APE1/Ref-1 in Experimental Murine Myocarditis.
Jin SA; Lim BK; Seo HJ; Kim SK; Ahn KT; Jeon BH; Jeong JO
Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29292734
[TBL] [Abstract][Full Text] [Related]
10. Elevated and altered expression of the multifunctional DNA base excision repair and redox enzyme Ape1/ref-1 in prostate cancer.
Kelley MR; Cheng L; Foster R; Tritt R; Jiang J; Broshears J; Koch M
Clin Cancer Res; 2001 Apr; 7(4):824-30. PubMed ID: 11309329
[TBL] [Abstract][Full Text] [Related]
11. Altered Secretory Activity of APE1/Ref-1 D148E Variants Identified in Human Patients With Bladder Cancer.
Lee YR; Lim JS; Shin JH; Choi S; Joo HK; Jeon BH
Int Neurourol J; 2016 May; 20(Suppl 1):S30-37. PubMed ID: 27230458
[TBL] [Abstract][Full Text] [Related]
12. Identification of plasma APE1/Ref-1 in lipopolysaccharide-induced endotoxemic rats: implication of serological biomarker for an endotoxemia.
Park MS; Lee YR; Choi S; Joo HK; Cho EJ; Kim CS; Park JB; Jo EK; Jeon BH
Biochem Biophys Res Commun; 2013 Jun; 435(4):621-6. PubMed ID: 23685156
[TBL] [Abstract][Full Text] [Related]
13. [Correlations between Ape1/Ref-1, ICAM-1 and IL-17A Levels in Serum and Radiation Pneumonitis for Local Advanced Non-small Cell Lung Cancer Patients].
Guo L; Ding G; Xu W; Ge H; Jiang Y; Lu Y
Zhongguo Fei Ai Za Zhi; 2018 May; 21(5):383-388. PubMed ID: 29764588
[TBL] [Abstract][Full Text] [Related]
14. APE1/Ref-1 enhances DNA binding activity of mutant p53 in a redox-dependent manner.
Cun Y; Dai N; Li M; Xiong C; Zhang Q; Sui J; Qian C; Wang D
Oncol Rep; 2014 Feb; 31(2):901-9. PubMed ID: 24297337
[TBL] [Abstract][Full Text] [Related]
15. Serum APE1 as a predictive marker for platinum-based chemotherapy of non-small cell lung cancer patients.
Zhang S; He L; Dai N; Guan W; Shan J; Yang X; Zhong Z; Qing Y; Jin F; Chen C; Yang Y; Wang H; Baugh L; Tell G; Wilson DM; Li M; Wang D
Oncotarget; 2016 Nov; 7(47):77482-77494. PubMed ID: 27813497
[TBL] [Abstract][Full Text] [Related]
16. The DNA base excision repair protein Ape1/Ref-1 as a therapeutic and chemopreventive target.
Fishel ML; Kelley MR
Mol Aspects Med; 2007; 28(3-4):375-95. PubMed ID: 17560642
[TBL] [Abstract][Full Text] [Related]
17. Apurinic apyrimidinic endonuclease/redox effector factor 1 immunoreactivity and grading in hepatocellular carcinoma risk of relapse after liver transplantation.
Avellini C; Orsaria M; Baccarani U; Adani GL; Lorenzin D; Bresadola V; Bresadola F; Beltrami CA
Transplant Proc; 2010 May; 42(4):1204-8. PubMed ID: 20534262
[TBL] [Abstract][Full Text] [Related]
18. Functional characterization of a promoter polymorphism in APE1/Ref-1 that contributes to reduced lung cancer susceptibility.
Lu J; Zhang S; Chen D; Wang H; Wu W; Wang X; Lei Y; Wang J; Qian J; Fan W; Hu Z; Jin L; Shen H; Huang W; Wei Q; Lu D
FASEB J; 2009 Oct; 23(10):3459-69. PubMed ID: 19541747
[TBL] [Abstract][Full Text] [Related]
19. Hydrogen peroxide activates APE1/Ref-1 via NF-κB and Parkin: a role in liver cancer resistance to oxidative stress.
Siswanto FM; Okukawa K; Tamura A; Oguro A; Imaoka S
Free Radic Res; 2023 Dec; 57(3):223-238. PubMed ID: 37364176
[TBL] [Abstract][Full Text] [Related]
20. Histone deacetylases inhibitor trichostatin A modulates the extracellular release of APE1/Ref-1.
Choi S; Lee YR; Park MS; Joo HK; Cho EJ; Kim HS; Kim CS; Park JB; Irani K; Jeon BH
Biochem Biophys Res Commun; 2013 Jun; 435(3):403-7. PubMed ID: 23665318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]